From a spine-specific operating table to new navigation systems, here is what to know about five technologies that have recently debuted and cleared or approved by the FDA.
1. Holo Portal is Surgalign’s artificial intelligence and augmented reality-powered surgical guidance system.
2. The system incorporates intraoperative images to plan screw placement trajectories and shows anatomy and pinpoints the paths using AR.
3. It was cleared by the FDA for lumbar spine procedures.
4. Mario Brkaric, MD, completed the first case with the Holo Portal system at Indiana Spine Hospital in Carmel.
5. Excelsius3D is a three-in-one imaging system that debuted in May at multiple hospitals across the country.
6. It is an X-ray system designed for 2D fluoroscopy, 2D digital radiography and 3D imaging. It is indicated for use where a physician benefits from 2D and 3D data on anatomic structures and high-contrast objects with high X-ray attenuation such as bony anatomy and metallic objects.
7. Excelsius3D is made to integrate with Globus Medical’s flagship spine robot.
8. Surgeons who debuted the technology were Paul McAfee, MD; Mesfin Lemma, MD; Roland Kent, MD, and Jeffrey Goldstein, MD.
9. The ProAxis spine table from Mizuho OSI can work with Excelsius3D.
10. It has Tempur-Pedic medical pad technology and IntelliPendant controls that allow for precise and consistent imaging.
11. Northwest Specialty Hospital in Post Falls, Idaho, debuted the technology.
12. The Q system is designed for advanced surgical planning and intraoperative guidance for open or percutaneous computer-assisted surgery.
13. It integrates with Stryker’s Spine Guidance Software, which is approved for use in patients 13 and older.
14. It received FDA 510(k) clearance for spine surgery applications.
15. VisAR, from Novarad, received FDA approval for intraoperative spine surgery.
16. It transforms imaging data into a 3D hologram that is visible and superimposed on the patient. Surgical accuracy is less than 2 millimeters for pedicle screw placement and minimally invasive spine cases.
17. VisAR is being considered for head and neck indications by the FDA.